Literature DB >> 34871741

Structural and dynamic insights into the HNH nuclease of divergent Cas9 species.

Helen B Belato1, Alexandra M D'Ordine1, Lukasz Nierzwicki2, Pablo R Arantes2, Gerwald Jogl1, Giulia Palermo3, George P Lisi4.   

Abstract

CRISPR-Cas9 is a widely used biochemical tool with applications in molecular biology and precision medicine. The RNA-guided Cas9 protein uses its HNH endonuclease domain to cleave the DNA strand complementary to its endogenous guide RNA. In this study, novel constructs of HNH from two divergent organisms, G. stearothermophilus (GeoHNH) and S. pyogenes (SpHNH) were engineered from their respective full-length Cas9 proteins. Despite low sequence similarity, the X-ray crystal structures of these constructs reveal that the core of HNH surrounding the active site is conserved. Structure prediction of the full-length GeoCas9 protein using Phyre2 and AlphaFold2 also showed that the crystallographic construct of GeoHNH represents the structure of the domain within the full-length GeoCas9 protein. However, significant differences are observed in the solution dynamics of structurally conserved regions of GeoHNH and SpHNH, the latter of which was shown to use such molecular motions to propagate the DNA cleavage signal. Indeed, molecular simulations show that the intradomain signaling pathways, which drive SpHNH function, are non-specific and poorly formed in GeoHNH. Taken together, these outcomes suggest mechanistic differences between mesophilic and thermophilic Cas9 species.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas9; HNH; MD simulations; NMR; Protein dynamics

Mesh:

Substances:

Year:  2021        PMID: 34871741      PMCID: PMC8917064          DOI: 10.1016/j.jsb.2021.107814

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  55 in total

1.  Rationally engineered Cas9 nucleases with improved specificity.

Authors:  Ian M Slaymaker; Linyi Gao; Bernd Zetsche; David A Scott; Winston X Yan; Feng Zhang
Journal:  Science       Date:  2015-12-01       Impact factor: 47.728

2.  Diversity and evolution of class 2 CRISPR-Cas systems.

Authors:  Sergey Shmakov; Aaron Smargon; David Scott; David Cox; Neena Pyzocha; Winston Yan; Omar O Abudayyeh; Jonathan S Gootenberg; Kira S Makarova; Yuri I Wolf; Konstantin Severinov; Feng Zhang; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2017-01-23       Impact factor: 60.633

3.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

4.  Dynamical networks in tRNA:protein complexes.

Authors:  Anurag Sethi; John Eargle; Alexis A Black; Zaida Luthey-Schulten
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-07       Impact factor: 11.205

5.  Structures of Neisseria meningitidis Cas9 Complexes in Catalytically Poised and Anti-CRISPR-Inhibited States.

Authors:  Wei Sun; Jing Yang; Zhi Cheng; Nadia Amrani; Chao Liu; Kangkang Wang; Raed Ibraheim; Alireza Edraki; Xue Huang; Min Wang; Jiuyu Wang; Liang Liu; Gang Sheng; Yanhua Yang; Jizhong Lou; Erik J Sontheimer; Yanli Wang
Journal:  Mol Cell       Date:  2019-10-24       Impact factor: 17.970

6.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

7.  Structural insights into DNA cleavage activation of CRISPR-Cas9 system.

Authors:  Cong Huai; Gan Li; Ruijie Yao; Yingyi Zhang; Mi Cao; Liangliang Kong; Chenqiang Jia; Hui Yuan; Hongyan Chen; Daru Lu; Qiang Huang
Journal:  Nat Commun       Date:  2017-11-09       Impact factor: 14.919

8.  Conformational control of DNA target cleavage by CRISPR-Cas9.

Authors:  Samuel H Sternberg; Benjamin LaFrance; Matias Kaplan; Jennifer A Doudna
Journal:  Nature       Date:  2015-10-28       Impact factor: 49.962

9.  Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch.

Authors:  Benjamin L Oakes; Dana C Nadler; Avi Flamholz; Christof Fellmann; Brett T Staahl; Jennifer A Doudna; David F Savage
Journal:  Nat Biotechnol       Date:  2016-05-02       Impact factor: 54.908

10.  A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells.

Authors:  Christopher A Vakulskas; Daniel P Dever; Garrett R Rettig; Rolf Turk; Ashley M Jacobi; Michael A Collingwood; Nicole M Bode; Matthew S McNeill; Shuqi Yan; Joab Camarena; Ciaran M Lee; So Hyun Park; Volker Wiebking; Rasmus O Bak; Natalia Gomez-Ospina; Mara Pavel-Dinu; Wenchao Sun; Gang Bao; Matthew H Porteus; Mark A Behlke
Journal:  Nat Med       Date:  2018-08-06       Impact factor: 53.440

View more
  4 in total

Review 1.  Dynamics and mechanisms of CRISPR-Cas9 through the lens of computational methods.

Authors:  Aakash Saha; Pablo R Arantes; Giulia Palermo
Journal:  Curr Opin Struct Biol       Date:  2022-06-08       Impact factor: 7.786

Review 2.  Structural biology of CRISPR-Cas immunity and genome editing enzymes.

Authors:  Joy Y Wang; Patrick Pausch; Jennifer A Doudna
Journal:  Nat Rev Microbiol       Date:  2022-05-13       Impact factor: 78.297

Review 3.  Emerging Methods and Applications to Decrypt Allostery in Proteins and Nucleic Acids.

Authors:  Pablo R Arantes; Amun C Patel; Giulia Palermo
Journal:  J Mol Biol       Date:  2022-02-28       Impact factor: 6.151

4.  Temperature dependent in vitro binding and release of target DNA by Cas9 enzyme.

Authors:  Serene Rose David; Sumanth Kumar Maheshwaram; Divya Shet; Mahesh B Lakshminarayana; Gautam V Soni
Journal:  Sci Rep       Date:  2022-09-09       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.